Clinical considerations in managing nausea associated with venlafaxine.
Amchin
J
J
Albano
D
D
D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D020117:Cisapride; D003511:Cyclohexanols / Q000009:adverse effects*; D003866:Depressive Disorder / Q000188:drug therapy; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D009325:Nausea / Q000517:prevention & control*; D010880:Piperidines / Q000627:therapeutic use*; D000069470:Venlafaxine Hydrochloride
D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D005765:Gastrointestinal Agents; D010880:Piperidines; D000069470:Venlafaxine Hydrochloride; D020117:Cisapride